Adeel R. Seyal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Adeel R. Seyal has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Borna E. Dabiri
Brigham and Women’s Hospital, Boston, USA
1 shared publication - Daniel Souza
Department of Radiology, Mass General Brigham, Brigham and Women's Hospital, Boston, MA, United States (D.S.).
1 shared publication - Eric R. Cosman
Cambridge Interventional, LLC, Burlington, USA
1 shared publication - Paul B. Shyn
Brigham and Women’s Hospital, Harvard Medical School
1 shared publication - Raquel O. Alencar
Department of Radiology, Abdominal Imaging and Intervention, Harvard Medical School, Brigham and Women’s Hospital, Boston, USA
1 shared publication - Ravi V. Gottumukkala
Brigham and Women’s Hospital, Boston, USA
1 shared publication
Latest Publications
- 10 October 2023
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (2) , 586-596
Feasibility and safety of bipolar radiofrequency track cautery during percutaneous image-guided abdominal biopsy procedures
Purpose The purpose of this study was to assess the feasibility and safety of using a bipolar radiofrequency track cautery device during percutaneous image-guided abdominal biopsy procedures in at-risk patients. Methods Forty-two patients (26–79 years old; female 44%) with at least one bleeding risk factor who underwent an abdominal image-guided (CT or US) biopsy and intended bipolar radiofrequency track cautery (BRTC) were retrospectively studied. An 18G radiofrequency electrode was inserted through a 17G biopsy introducer needle immediately following coaxial 18G core biopsy, to cauterize the biopsy track using temperature control. Bleeding risk factors, technical success, and adverse events were recorded. Results BRTC was technically successful in 41/42 (98%) of procedures; in one patient, the introducer needle retracted from the liver due to respiratory motion prior to BRTC. BRTC following percutaneous biopsy was applied during 41 abdominal biopsy procedures (renal mass = 12, renal parenchyma = 10, liver mass = 9, liver parenchyma = 5, splenic mass or parenchyma = 4, gastrohepatic mass = 1). All patients had one or more of the following risk factors: high-risk organ (spleen or renal parenchyma), hypervascular mass, elevated prothrombin time, renal insufficiency, thrombocytopenia, recent anticoagulation or anticoagulation not withheld for recommended interval, cirrhosis, intraprocedural hypertension, brisk back bleeding observed from the introducer needle, or subcapsular tumor location. No severe adverse events (grade 3 or higher) occurred. Two (2/41, 5%) mild (grade 1) bleeding events did not cause symptoms or require intervention. Conclusion Bipolar radiofrequency track cautery was feasible and safe during percutaneous image-guided abdominal biopsy procedures. IRB approval: MBG 2022P002277 Graphical abstract
- 10 October 2023
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (2) , 586-596
Feasibility and safety of bipolar radiofrequency track cautery during percutaneous image-guided abdominal biopsy procedures
Purpose The purpose of this study was to assess the feasibility and safety of using a bipolar radiofrequency track cautery device during percutaneous image-guided abdominal biopsy procedures in at-risk patients. Methods Forty-two patients (26–79 years old; female 44%) with at least one bleeding risk factor who underwent an abdominal image-guided (CT or US) biopsy and intended bipolar radiofrequency track cautery (BRTC) were retrospectively studied. An 18G radiofrequency electrode was inserted through a 17G biopsy introducer needle immediately following coaxial 18G core biopsy, to cauterize the biopsy track using temperature control. Bleeding risk factors, technical success, and adverse events were recorded. Results BRTC was technically successful in 41/42 (98%) of procedures; in one patient, the introducer needle retracted from the liver due to respiratory motion prior to BRTC. BRTC following percutaneous biopsy was applied during 41 abdominal biopsy procedures (renal mass = 12, renal parenchyma = 10, liver mass = 9, liver parenchyma = 5, splenic mass or parenchyma = 4, gastrohepatic mass = 1). All patients had one or more of the following risk factors: high-risk organ (spleen or renal parenchyma), hypervascular mass, elevated prothrombin time, renal insufficiency, thrombocytopenia, recent anticoagulation or anticoagulation not withheld for recommended interval, cirrhosis, intraprocedural hypertension, brisk back bleeding observed from the introducer needle, or subcapsular tumor location. No severe adverse events (grade 3 or higher) occurred. Two (2/41, 5%) mild (grade 1) bleeding events did not cause symptoms or require intervention. Conclusion Bipolar radiofrequency track cautery was feasible and safe during percutaneous image-guided abdominal biopsy procedures. IRB approval: MBG 2022P002277 Graphical abstract